Vor Biopharma (VOR) Other Accumulated Expenses (2020 - 2026)
Vor Biopharma (VOR) reported Other Accumulated Expenses of $698000.0 for Q1 2026, up 6.4% year-over-year from $656000.0 in Q1 2025, and up 25.99% quarter-over-quarter from $554000.0 in Q4 2025.
Vor Biopharma (VOR) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Other Accumulated Expenses data on file, last reported at $698000.0 in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $698000.0, up 6.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $698000.0 (up 6.4% YoY), and the FY2025 annual result was $554000.0, up 55.62% from the prior year.
- Other Accumulated Expenses improved to $698000.0 in Q1 2026 per VOR's latest filing, from $554000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $2.4 million in Q3 2023 and troughed at $25000.0 in Q2 2024.
- A 5-year average of $558647.1 and a median of $351000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses soared 909.87% in 2023, then slumped 94.71% in 2024.
- A 5-year view of Other Accumulated Expenses shows it stood at $351000.0 in 2022, then declined by 21.94% to $274000.0 in 2023, then advanced by 29.93% to $356000.0 in 2024, then jumped by 55.62% to $554000.0 in 2025, then gained by 25.99% to $698000.0 in 2026.
- Business Quant data shows VOR's Other Accumulated Expenses at $698000.0 in Q1 2026, $554000.0 in Q4 2025, and $35000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vor Biopharma | 627.54 Mn | 627.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 698,000.00 |
| Dec 31, 2025 | 554,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 656,000.00 |
| Dec 31, 2024 | 356,000.00 |
| Sep 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Dec 31, 2023 | 274,000.00 |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | 473,000.00 |
| Mar 31, 2023 | 179,000.00 |
| Dec 31, 2022 | 351,000.00 |
| Sep 30, 2022 | 233,000.00 |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | 351,000.00 |
| Dec 31, 2021 | 797,000.00 |
| Sep 30, 2021 | 173,000.00 |
| Jun 30, 2021 | 1.04 Mn |